Review
Neural and molecular mechanisms in anxiety
- PMID: 2859577
Item in Clipboard
Review
Neural and molecular mechanisms in anxiety
Psychiatr Clin North Am.
1985 Mar.
Abstract
The recent discoveries of the benzodiazepine receptor and of antagonist compounds, such as beta-CCE, have advanced our understanding of the neurochemistry of anxiety. In this review we summarize the evidence implicating the benzodiazepine receptor in anxiety and relate this model to other models of anxiety.
Similar articles
-
Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.J Neurosci Methods. 2009 May 30;180(1):97-105. doi: 10.1016/j.jneumeth.2009.03.007. Epub 2009 Mar 21. J Neurosci Methods. 2009. PMID: 19427535
-
[Neurobiological approach to anxiety].Arch Mal Coeur Vaiss. 1987 May;80 Spec No:43-6. Arch Mal Coeur Vaiss. 1987. PMID: 2889436 French. No abstract available.
-
[Biochemical aspects of anxiety].Sem Hop. 1982 Dec 2;58(44):2573-9. Sem Hop. 1982. PMID: 6130605 Review. French.
-
[Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].Ann Med Psychol (Paris). 1993 Jan;151(1):47-63. Ann Med Psychol (Paris). 1993. PMID: 7905724 Review. French.
-
Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.Can J Psychiatry. 1993 Nov;38 Suppl 4:S109-13. Can J Psychiatry. 1993. PMID: 7905780 Review.
Cited by
-
FG 7142 selectively decreases nonpunished responding, but has no anxiogenic effects on time allocation in a conflict schedule.Psychopharmacology (Berl). 1992;108(1-2):185-8. doi: 10.1007/BF02245305. Psychopharmacology (Berl). 1992. PMID: 1329131